Computational biology involves the development and application of data-analytical and theoretical methods, mathematical modeling and computational simulation techniques to the study of biological, behavioral, and social systems. Computational approaches have gained prominence in drug discovery, disease risk prediction, gene sequencing, and precision medicine. Computational biology helps accelerate biological research and reduce costs by utilizing supercomputing tools for high-throughput data analysis.
The global Computational Biology Market is estimated to be valued at US$ 6.6 Bn in 2023 and is expected to exhibit a CAGR of 4.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
Advancements in computational biology application tools is one of the key trends driving the growth of the global computational biology market. Continuous innovations are helping researchers and scientists analyze large and complex biological data more efficiently. For instance, machine learning and artificial intelligence based tools are enabling researchers to identify patterns, relationships and insights hidden in biological data that would have otherwise taken years using traditional analytical approaches. These advanced applications are accelerating drug discovery and precision medicine approaches by powering researchers to simulate disease mechanisms, predict drug toxicity and efficacy faster than before. Companies offering innovative computational biology solutions are focusing on integrating latest technologies like cloud and high performance computing which is further propelling the market growth.
Segment Analysis
The global computational biology market is segmented based on technology, services, application, and end user. By technology, sequence alignment segment held the largest market share in 2024 owing to the wide usage of sequence alignment techniques in biological data analysis such as identification of proteins, genomes, and gene expression. By services, in silico segment dominated the market as it provides cost-effective analysis and reduces timelines for drug discovery and disease modeling.
Key Takeaways
The Global Computational Biology Market Demand is expected to witness high growth during the forecast period. By 2030, the market size is projected to reach around US$ 14.7 Bn exhibiting a CAGR of 4.8%. The growth can be attributed to the increasing R&D investments in biomedicine and drug discovery along with rising adoption of computational techniques.
Regional analysis
Regionally, North America held the largest share of the computational biology market in 2024 driven by strong presence of leading pharmaceutical and biotechnology companies in the region. Asia Pacific is expected to grow at the fastest pace during the forecast period owing to growth in genomics research and ongoing initiatives by government towards development of computational infrastructure in countries such as China and India.
Key players
Key players operating in the computational biology market are GlaxoSmithKline (GSK), Bayer AG, Amway Corporation, Church & Dwight Co. Inc., Nestle SA. GlaxoSmithKline (GSK) is one of the
strong product portfolio and R&D capabilities in computational drug discovery. Amway Corporation focuses on disease modeling through its in-house computational platform.
Explore more information on this topic, Please visit-
Explore more trending article related this topic:
https://masstamilan.in/cancer-therapy-the-future-looks-promising/
